A substance being studied in the treatment of liver cancer
. It is made by attaching a radioactive
substance called indium 111 to a monoclonal antibody
. HuAFP31 binds to tumor
cells that make alpha fetoprotein (AFP), and the indium In 111 may kill the tumor cells. It is a type of radioimmunoconjugate.